Literature DB >> 31213419

Starting the conversation: CRISPR's role in India.

Farhad Udwadia1, Shivam Singh2.   

Abstract

The applications of gene editing technologies such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) have grown significantly in recent years. Several countries have adopted different stances on the regulation of such technology; however, India does not have any legally enforceable regulations in place. There is a need for such a development as India's regulatory, sociocultural, and economic landscape is unique. First, we discuss the uncertainty regarding India's regulatory capacity to enforce ethical standards for CRISPR use. Then, we discuss unique driving forces that could lead to the misuse of CRISPR in India, such as certain sociocultural norms like preferences for fair skin and public demand for sex determination. Given these previous concerns, we posit the question; where on the priority list does CRISPR stand in the context of public health in India?

Year:  2019        PMID: 31213419     DOI: 10.20529/IJME.2019.016

Source DB:  PubMed          Journal:  Indian J Med Ethics        ISSN: 0974-8466


  2 in total

1.  Estimated economic burden of cancer associated with suboptimal diet in the United States.

Authors:  Fang Fang Zhang; Jaya S Khushalani; Frederick P Cudhea; Donatus U Ekwueme; Mengyuan Ruan; Zhilei Shan; Diane M Harris; Dariush Mozaffarian
Journal:  Cancer Causes Control       Date:  2021-10-15       Impact factor: 2.532

2.  Engagement and social acceptance in genome editing for human benefit: Reflections on research and practice in a global context.

Authors:  Sebastián Barbosa; Léa Paré Toé; Delphine Thizy; Manjulika Vaz; Lucy Carter
Journal:  Wellcome Open Res       Date:  2020-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.